Medicare vs. private payers: How rates differ for 10 hospital services

Medicare vs. private payers: How rates differ for 10 hospital services On average, private health insurers' payment rates are between 1.6 and 2.5 times higher than Medicare, according to a data brief from the Kaiser Family Foundation. The brief examines hospital payments from private payers and Medicare for 10 inpatient services. Data is from the IBM MarketScan Commercial Claims and Encounters Database and public Medicare payment and utilization data for 2014-17. For each service, KFF compared average payments made by private health plans and Medicare. Here is how payment rates differed between private payers and Medicare for 10 inpatient services. The dollar amounts are averages in 2017. Respiratory diagnoses related to COVID-19* Respiratory with a ventilator for more than 96 hours (DRG 207) Private payers: $100,461 Medicare: $40,218 Respiratory with a ventilator for up to 96 hours (DRG 208) Private payers: $36,758 Medicare: $17,437 Respiratory infections (DRG 177) Private payers: $33,786 Medicare: $13,297 *As the numbers are from 2017, the Medicare payment rates don't include the 20 percent add-on hospitals now get for treating COVID-19 patients. KFF said had this add-on been in effect in 2017, the difference would be smaller, but private payment rates would still be about double Medicare rates. Common diagnoses Angioplasty (DRG 247) Private payers: $35,321 Medicare: $15,782 Bowel (DRG 330) Private payers: $32,733 Medicare: $18,940 Knee and hip (DRG 470) Private payers: $30,099 Medicare: $14,747 Bariatric (DRG 621) Private payers: $22,179 Medicare: $11,531 Uterus (DRG 743) Private payers: $14,444 Medicare: $9,232 Gastroenteritis (DRG 392) Private payer: $11,055 Medicare: $5,872 Cellulitis (DRG 603) Private payers: $10,980 Medicare: $6,511 View the full data brief here. More articles on healthcare finance: Trinity Health furloughs, lays off another 1,000 workers State-by-state breakdown of 36 critical access hospital closures Saint Luke's Health System to close Kansas hospital © Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
Targets
-
Drugs
-
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.